Dinutuximab beta Clinical Trials

3 actively recruiting trials

Also known as: Immunotherapy

Pipeline

Phase 1: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

University of Birmingham1
Princess Maxima Center for Pediatric Oncology1
N.N. Petrov National Medical Research Center of Oncology1

Indications

Cancer3
Alveolar Rhabdomyosarcoma1
Embryonal Rhabdomyosarcoma1
Bone Sarcoma1
Neuroblastoma1

Other3 trials

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

Phase 1/2

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas

Phase 3

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.